GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **851 - 875** of **4050** in total

« First

‹ Prev

…

31

32

33

34

35

36

37

38

39

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	24	mild	G17266GE	365
IgG	Patient 2	15	mild	G17266GE	41
IgG	Patient 2	24	mild	G17266GE	51
IgM	Patient 2	15	mild	G17266GE	146
IgM	Patient 2	24	mild	G17266GE	227
IgA	Patient 2	3	mild	G17266GE	336
IgG	Patient 2	3	mild	G17266GE	48
IgM	Patient 2	3	mild	G17266GE	199
IgA	Patient 3	-180	mild	G17266GE	285
IgA	Patient 3	11	mild	G17266GE	476
IgG	Patient 3	-180	mild	G17266GE	57
IgG	Patient 3	11	mild	G17266GE	135
IgM	Patient 3	-180	mild	G17266GE	117
IgA	Patient 3	4	mild	G17266GE	524
IgG	Patient 3	4	mild	G17266GE	141
IgM	Patient 3	11	mild	G17266GE	487
IgM	Patient 3	4	mild	G17266GE	578
IgA	Patient 4	12	mild	G17266GE	634
IgG	Patient 4	12	mild	G17266GE	167
IgM	Patient 4	12	mild	G17266GE	911
IgA	Patient 1	10	moderate	G17390SF	387
IgA	Patient 1	22	moderate	G17390SF	381
IgA	Patient 1	6	moderate	G17390SF	348
IgG	Patient 1	10	moderate	G17390SF	25
IgG	Patient 1	22	moderate	G17390SF	28